Differential effects of retinoic acid on growth and apoptosis in human colon cancer cell lines associated with the induction of retinoic acid receptor β

Biochemical Pharmacology

Volumn 59, Issue 5, 2000, Pages 485-496

  Lee, Mi Ock ^a   Han, Sun Young ^a   Jiang, Shunai ^a   Han Park, Jeon ^a   Kim, Se Jong ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

All trans retinoic acid; Apoptosis; Colon cancer; RAR

Indexed keywords

CELL DNA; DNA FRAGMENT; MYC PROTEIN; PROTEIN BAX; PROTEIN BCL 2; RECEPTOR SUBUNIT; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL MEMBRANE; CELL SPECIFICITY; CELL STRUCTURE; CHROMATIN CONDENSATION; CLONING VECTOR; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA CLEAVAGE; DRUG MECHANISM; DRUG RESISTANCE; DRUG SENSITIVITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL DIVISION; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, RETINOIC ACID; TRANSFECTION; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0033971920     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00355-X     Document Type: Article

References (44)

1. Gudas L., Sporn M.B., Roberts A.B. Cellular biology and biochemistry of the retinoids. Sporn M.B., Roberts A.B., Goodman D.S. The Retinoids. 2nd ed. 1994;443-520 Raven Press, New York.
2. Moon R.C., Mehta R.G. Chemoprevention of mammary cancer by retinoids. Basic Life Sci. 52:1990;213-224.
3. Lippman S.M., Kessler J.F., Meyksens F.L. Retinoids as preventive and therapeutic anticancer agents. Cancer Treat Rep. 71:1987;493-515.
4. Pfahl M., Apfel R., Bendik I., Fanjul A., Graupner G., Lee M.-O., LaVista N., Lu X.-P., Piedrafita J., Ortiz M.A., Salbert G., Zhang X.-K. Nuclear retinoid receptors and their mechanism of action. Litwack G. Vitamins and Hormones Steroids. Vol. 49:1994;327-381 Academic Press, San Diego.
5. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. The nuclear receptor superfamily The second decade. Cell. 83:1995;835-839.
6. Geber J.F., Moghal N., Frangioni J.V., Sugarbaker D.J., Neel B.G. High frequency of retinoic acid receptor β abnormalities in human lung cancer. Oncogene. 6:1991;1859-1868.
7. Hu L., Crowe L., Rheinwald J.G., Chambon P., Gudas L. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res. 51:1991;3972-3981.
8. Zhang X.-K., Liu Y., Lee M.-O., Pfahl M. A specific defect in the retinoic acid response associated with human lung cancer cell lines. Cancer Res. 54:1994;5663-5669.
9. Liu Y., Lee M.-O., Wang H.-G., Li Y., Hashimoto Y., Klaus M., Reed J.C., Zhang X.-K. Retinoic acid receptor mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol. 16:1996;1138-1149.
10. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119:1992;493-501.
11. Shaw P., Bovey R., Tardy S., Sahli R., Sordat B., Costa J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA. 89:1992;4495-4499.
12. Bedi A., Pasricha P.J., Akhtar A.J., Barber J.P., Bedi G.C., Giardiello F.M., Zehnbauer B.A., Hamilton S.R., Jones R.J. Inhibition of apoptosis during development of colorectal cancer. Cancer Res. 55:1995;1811-1816.
13. Kikuchi Y., Dinjens W.N., Bosman F.T. Proliferation and apoptosis in proliferative lesions of the colon and rectum. Virchows Arch. 431:1997;111-117.
14. Baretton G.B., Diebold J., Christoforis G. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Cancer. 77:1996;255-264.
15. Hague A., Manning A.M., Hanlon K.A., Huschtscha L.I., Hart D., Paraskeva C. Sodium butyrate induces apoptosis in human colonic tumor cell lines in a p53-independent pathway Implications for the possible role of dietary fiber in the prevention of large-bowel cancer. Int J Cancer. 55:1993;498-505.
16. Shchepotin I.B., Soldatenkov V., Bruas R.R., Nauta R.J., Shabahang M., Evans S.R. Apoptosis of human primary and metastatic colon adenocarcinoma cell lines in vitro induced by 5-fluorouracil, verapamil, and hyperthermia. Anticancer Res. 14:1994;1027-1031.
17. Wang C.Y., Eshleman J.R., Willson J.K., Markowitz S. Both transforming growth factor-β and substrate release are inducers of apoptosis in a human colon adenoma cell line. Cancer Res. 55:1995;5101-5105.
18. Elder D.J., Hague A., Hicks D.J., Paraskeva C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines Enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Res. 56:1996;2273-2276.
19. Willett W.C., Hunter D.J. Vitamin A and cancers of the breast, large bowel and prostate Epidermiologic evidence. Nutr Rev. 52:1994;S53-S59.
20. Stopera S.A., Bird R.P. Effects of all-trans retinoic acid as a potential chemopreventive agent on the formation of azoxymethane-induced aberrant crypt foci differential expression of c-myc and c-fos mRNA and protein. Int J Cancer. 53:1993;798-804.
21. Kawamori T., Tanaka T., Hirose Y., Satoh K., Hara A., Torihara M., Tamai Y., Yamahara J., Mori H. Suppression of azoxymethane-induced colonic aberrant crypt foci by dietary exposure to a novel synthesized retinoidal butenolide, 5-hydroxy-4-(2-phenyl-(E)ethenyl-2(5H)-furanone, in rats. Cancer Res. 92:1995;159-165.
22. 3 are differentially modified by 9-cis retinoic acid. Cancer Res. 56:1996;623-632.
23. Stewart L.V., Thomas M.L. Retinoids differentially regulate the proliferation of colon cancer cell lines. Exp Cell Res. 233:1997;321-329.
24. Bruel G., Benoit G., De Nay D., Brown S., Lanotte M. Distinct apoptotic responses in maturation sensitive and resistant t (15;17) acute promyelocytic leukemia N84 cells. 9-cis retinoic acid induces apoptosis independent of maturation and Bcl-2 expression. Leukemia. 9:1995;1173-1184.
25. Piedrafita J., Pfahl M. Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation. Mol Cell Biol. 17:1997;6348-6358.
26. McCormack S.A., Viar M.J., Tague L., Johnson L.R. Altered distribution of the nuclear receptor RAR beta accompanies proliferation and differentiation changes caused by retinoic acid in Caco-2 cells. In Vitro Cell Dev Biol Anim. 32:1996;53-61.
27. van der Burg B., van der Leede B.M., Kwakkenbos-Isbrucker L., Salverda S., de laat S.W., van der Saag P.T. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol Cell Endocrinol. 91:1993;149-157.
28. Lotan R., Xu X.C., Lippman S.M., Ro J.Y., Lee J.S., Lee J.J., Hong W.K. Suppression of retinoic acid receptor-β in premalignant oral lesions and its up-regulation by isotretinoin. N Eng J Med. 332:1995;1405-1410.
29. Anzick S.L., Kononen J., Walker R.L., Azorsa D.O., Tanner J.J., Guan X.Y., Sauter G., Kallioniemi O.P., Trent J.M., Meltzer P.S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science. 277:1997;965-968.
30. Cote S., Momparler R.L. Activation of the retinoic acid receptor β gene by 5-aza-2′-deoxycytidine in human DLD-1 colon carcinoma cells. Anticancer Drugs. 8:1997;56-61.
31. 2 expression in SK-N-BE2© neuroblastoma cells and regulate a differentiation-apoptosis switch. Mol Cell Biol. 18:1998;6482-6492.
32. Hague A., Hicks M.D., Chapman M., Paraskeva C. Bcl-2 expression in human colorectal adenomas and carcinomas. Oncogene. 9:1994;3367-3370.
33. Langlois N.E., Lamb J., Eremin O., Heys S.D. Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under Relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products. J Pathol. 182:1997;392-397.
34. Kawasaki Y., Monden T., Morimoto H., Murotani M., Miyoshi Y., Kobayashi T., Shimano T., Mori T. Immunohistochemical study of p53 expression in microwave-fixed, paraffin-embedded sections of colorectal carcinoma and adenoma. Am J Clin Pathol. 97:1992;244-249.
35. Krajewska M., Moss S.F., Krajewska S., Song K., Holt P.R., Reed J.C. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res. 56:1996;2422-2427.
36. Tsujitani S., Shirai H., Tatebe S., Sugamura K., Ohfuji S., Gomyo Y., Maeta M., Ito H., Kaibara N. Apoptotic cell death and its relationship to carcinogenesis in colorectal carcinoma. Cancer. 77:(Suppl 8):1996;1711-1716.
37. Sakao Y., Noro M., Sekin S., Nozue M., Hirohashi S., Itoh T., Noguchi M. Microsatellite instability and frameshift mutations in the Bax gene in hereditary nonpolyposis colorectal carcinoma. Jpn J Cancer Res. 89:1998;1020-1027.
38. Nita M.E., Nagawa H., Tominaga O., Tsuno N., Fujii S., Sasaki S., Fu C.G., Takenoue T., Tsuruo T., Muto T. 5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins. Br J Cancer. 78:1998;9986-9992.
39. Marcu K.B., Bossone S.A., Patel A.J. myc function and regulation. Annu Rev Biochem. 61:1992;809-860.
40. Shi Y., Glynn J.M., Guilbert L.J., Cotter T.G., Bissonnette R.P., Green D.R. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science. 257:1992;212-214.
41. Klefstrom J., Vastrik I., Saksela E., Valle J., Eilers M., Alitalo K. c-myc induces cellular susceptibility to the cytotoxic action of TNF-α EMBO J. 13:1994;5442-5450.
42. Dong J., Natio M., Tsuruo T. c-Myc plays a role in cellular susceptibility to death receptor-mediated and chemotherapy-induced apoptosis in human monocytic leukemia U937 cells. Oncogene. 15:1997;639-647.
43. Lewis B.C., Shim H., Li Q., Wu C.S., Lee L.A., Maity A., Dang C.V. Identification of putative c-myc-responsive genes Characterization of rcl, a novel growth-related gene. Mol Cell Biol. 17:1997;4967-4978.
44. Hueber A.O., Zornig M., Lyon D., Suda T., Nagata S., Evan G.I. Requirement for the CD95 receptor-ligand pathway in c-myc-induced apoptosis. Science. 278:1997;1305-1309.